Stek advises Abacus on its acquisition of Pluripharm

Danish pharmaceutical supplier Abacus Medicine A/S has acquired Dutch pharmaceutical wholesaler Pluripharm Group. The group is one of four leading pharmaceutical wholesalers in the Netherlands with a full line of medicines, medical devices and services. Stek advised on the acquisition including the merger control proceeding before the Dutch Competition Authority.

Please click here for the press release.

Lawyers

Practice Areas

This might also interest you

Stek advises Stedin on equity issue to 23 provinces and municipalities as new shareholders

Stek has advised grid operator Stedin Group on an equity issue of € 34,8 million to 23 new shareholders being …

Read more

Stek again victorious for USG on allocation of costs for the transportation of electricity to SABIC

Stek has successfully represented Utility Support Group (USG) B.V. (“USG”) in the continuation of its dispute with SABIC Petrochemicals B.V. …

Read more

Stek victorious for distribution system operator Liander in transmission capacity dispute

Stek successfully represented distribution system operator Liander in summary proceedings before the Gelderland District Court against one of its customers. …

Read more